Commentary by Sue Shapses, PhD and Eva Winning Jepsen, MD

About Commentary by Sue Shapses, PhD and Eva Winning Jepsen, MD

Sue Shapses, PhD is a Professor at Rutgers University in New Brunswick, NJ. Her areas of research include osteoporosis, bone metabolism and obesity.

Eva Winning Jepsen, MD is with the Department of Biomedical Sciences and the Novo Nordisk Foundation Center for Basic Metabolic Research at the University of Copenhagen in Denmark.

 

 

Articles Written by Commentary by Sue Shapses, PhD and Eva Winning Jepsen, MD

Liraglutide May Prevent Weight-Loss Induced Bone Loss
While weight loss often leads to decreased bone mineral content and increases the risk for bone fractures, new findings suggest that the GLP-1 receptor agonist liraglutide may prevent this bone loss when used for chronic weight management.

Financial Disclosures for Commentary by Sue Shapses, PhD and Eva Winning Jepsen, MD

EndocrineWeb, a Vertical Health, LLC website, is committed to ensuring that the medical information it presents is accurate, balanced, objective, and trustworthy.

To help achieve this goal, EndocrineWeb requires all authors, editors, and reviewers to disclose any financial relationships or affiliations they have with companies whose products or services may be mentioned in the content they author, edit, or review.

The intent of this policy is to identify any perceived, potential, or real conflicts of interest so that readers can make their own judgments about the value of information being presented.

This author has not disclosed any realtionships
SHOW MAIN MENU
SHOW SUB MENU